Similar articles

• Aspirin for cerebral transient ischemic attacks or minor ischemic strokes.

  Chang TW. Chang TW. N Engl J Med. 1992 May 7;326(19):1288-9. doi: 10.1056/NEJM199205073261911. N Engl J Med. 1992. PMID: 1343814 Clinical Trial. No abstract available.
• ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].

  Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Touboul D, Touboul PJ. Bousser MG, et al. Rev Neurol (Paris). 1981;137(5):333-41. Rev Neurol (Paris). 1981. PMID: 7027408 Clinical Trial. French. No abstract available.
• [Transient ischemic attacks and prolonged reversible ischemic neurologic deficit. Diagnosis, differential diagnosis and treatment].

  Mosso M, Baumgartner RW. Mosso M, et al. Praxis (Bern 1994). 2000 Mar 23;89(13):542-8. Praxis (Bern 1994). 2000. PMID: 10776056 Review. German.
• [Medical treatment of ischemic cerebrovascular disease].

  Fogelholm R. Fogelholm R. Duodecim. 1985;101(22):2230-5. Duodecim. 1985. PMID: 4076019 Finnish. No abstract available.
• Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.

  Biller J. Biller J. J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. J Neurol Sci. 2009. PMID: 19380153 Review.